- Features
- Performances
- Specifications
- References
- Julius et al.
- Dextran-sulfate-adsorption of atherosclerotic lipoproteins from whole blood or separated plasma for lipid-apheresis--comparison of performance characteristics with DALI and Lipidfiltration.
- J Clin Apher. 22:215-23, 2007.
- Julius et al.
- The Dresden Apheresis Center - experience with LDL apheresis and immunoadsorption.
- Atheroscler Suppl.10:12-6,2009.
- Hovland et al.
- Patient tolerance regarding different low-density lipoprotein apheresis columns: frequent minor side effects and high patient satisfaction.
- J Clin Lipidol. 5:45-9,2011.
- Kamstrup et al.
- Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study.
- Circulation.117:176-84,2008.
- Jaeger et al.
- Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events.
- Nat Clin Pract Cardiovasc Med.6:229-39,2009.
- Leebmann et al.
- Lipoprotein apheresis in patients with maximally tolerated lipid-lowering therapy, lipoprotein(a)- hyper lipoproteinemia, and progressive cardiovascular disease: prospective observational multicenter study.
- Circulation. 128: 2567-76,2013.
- Hirai et al.
- Significance of low-level DSA detected by solid-phase assay in association with acute and chronic antibody- mediated rejection.
- Transpl Int.25:925-34,2012.
- Yamaji et al.
- Long-term clinical outcomes of synchronized therapy with plasmapheresis and intravenous cyclophosphamide pulse therapy in the treatment of steroid-resistant lupus nephritis.
- Ther Apher Dial.12:298-305,2008.
- Liu et al.
- Successful treatment of patients with systemic lupus erythematosus complicated with autoimmune thyroid disease using double-filtration plasmapheresis: a retrospective study.
- J Clin Apher. 26:174-80,2011.
- Kasuya et al.
- Clearance efficacy of autoantibodies in double filtration plasmapheresis for pemphigus foliaceus.
- Acta Derm Venereol.93:181-2,2013.
- Kitabata et al.
- Double filtration plasmapheresis for the treatment of bullous pemphigoid: a three case report.
- Ther Apher. 5:484-90,2001.
- Weiss.
- A critical review on the use of lipid apheresis and rheopheresis for treatment of peripheral arterial disease and the diabetic foot syndrome.
- Semin Dial. 25:220-7,2012.
- Ferrannini et al.
- Rheopheresis in vascular diseases.
- Int J Artif Organs.30:923-9,2007.
- Klingel et al.
- Rheopheresis in patients with ischemic diabetic foot syndrome: results of an open label prospective pilot trial.
- Ther Apher Dial.7:444-55,2003.
- Kim et al.
- Double-filtration plasmapheresis for the treatment of patients with recalcitrant atopic dermatitis.
- Ther Apher Dial.17:631-7,2013.
- Isoda et al.
- Microscopic polyangiitis complicated with cerebral infarction and hemorrhage: a case report and review of literature.
- Nihon Rinsho Meneki Gakkai Kaishi.33:111-5,2010. JAPANESE
- Zhang et al.
- Comparison of double filtration plasmapheresis with immunoadsorption therapy in patients with anti-glomerular basement membrane nephritis.
- BMC Nephrol. 15:128,2014.
- Koss et al.
- Prospective, randomized, controlled clinical study evaluating the efficacy of Rheopheresis for dry age-related macular degeneration. Dry AMD treatment with Rheopheresis Trial-ART.
- Graefes Arch Clin Exp Ophthalmol. 247:1297-306, 2009.
Trademark
Cascadeflo is a trademark of Asahi Kasei Medical Co., Ltd.
![](/medical/en/apheresis/product/plasma/ec/img/img_download.jpg)
Cascadeflo EC
Please feel free to send us any questions you may have about our products and support.
Share your feelings and experiences when using our products.